Matthew T. Knuesel

Matthew T. Knuesel

Auto-generated profile, based on publicly available information

Matthew T. Knuesel

Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2017 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
EWEmily R. Weikum
Emily R. Weikum
MKMatthew T. Knuesel
Matthew T. Knuesel
EOEric A. Ortlund
Eric A. Ortlund
KYKeith R. Yamamoto
Keith R. Yamamoto

15 February 2009 in Genes & Development
Verified
Journal Article
Closed access
PDF file
MKMatthew T. Knuesel
Matthew T. Knuesel
KMKrista D. Meyer
Krista D. Meyer
CBCarrie Bernecky
Carrie Bernecky
DTDylan J. Taatjes
Dylan J. Taatjes
The human CDK8 subcomplex (CDK8, cyclin C, Med12, and Med13) negatively regulates transcription in ways not completely defined; past studies suggested CDK8 kinase activity was required for its repressive function. Using a reconstituted transcription system together with recombinant or endogenous CDK8 subcomplexes, we demonstrate that, in fact, Med12 and Med13 are critical for subcomplex-dependent repression, whereas CDK8 kinase activity is not. A hallmark of activated transcription is efficient reinitiation from promoter-bound scaffold complexes that recruit a series of pol II enzymes to the gene. Notably, the CDK8 submodule strongly represses even reinitiation events, suggesting a means to fine tune transcript levels. Structural and biochemical studies confirm the CDK8 submodule binds the Mediator leg/tail domain via the Med13 subunit, and this submodule–Mediator association precludes pol II recruitment. Collectively, these results reveal the CDK8 subcomplex functions as a simple switch that controls the Mediator–pol II interaction to help regulate transcription initiation and reinitiation events. As Mediator is generally required for expression of protein-coding genes, this may reflect a common mechanism by which activated transcription is shut down in human cells.

1 February 2009 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
MKMatthew T. Knuesel
Matthew T. Knuesel
KMKrista D. Meyer
Krista D. Meyer
ADAaron J. Donner
Aaron J. Donner
JEJoaquin M. Espinosa
Joaquin M. Espinosa
DTDylan J. Taatjes
Dylan J. Taatjes
The four proteins CDK8, cyclin C, Med12, and Med13 can associate with Mediator and are presumed to form a stable "CDK8 subcomplex" in cells. We describe here the isolation and enzymatic activity of the 600-kDa CDK8 subcomplex purified directly from human cells and also via recombinant expression in insect cells. Biochemical analysis of the recombinant CDK8 subcomplex identifies predicted (TFIIH and RNA polymerase II C-terminal domain [Pol II CTD]) and novel (histone H3, Med13, and CDK8 itself) substrates for the CDK8 kinase. Notably, these novel substrates appear to be metazoan-specific. Such diverse targets imply strict regulation of CDK8 kinase activity. Along these lines, we observe that Mediator itself enables CDK8 kinase activity on chromatin, and we identify Med12--but not Med13--to be essential for activating the CDK8 kinase. Moreover, mass spectrometry analysis of the endogenous CDK8 subcomplex reveals several associated factors, including GCN1L1 and the TRiC chaperonin, that may help control its biological function. In support of this, electron microscopy analysis suggests TRiC sequesters the CDK8 subcomplex and kinase assays reveal the endogenous CDK8 subcomplex--unlike the recombinant submodule--is unable to phosphorylate the Pol II CTD.

1 November 2003 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
MKMatthew Knuesel
Matthew Knuesel
YWYong Wan
Yong Wan
ZXZhan Xiao
Zhan Xiao
EHEric Holinger
Eric Holinger
NLNick Lowe
Nick Lowe
XLXuedong Colorado- Liu
Xuedong Colorado- Liu
Identification of protein-protein interactions is essential for elucidating the biochemical mechanism of signal transduction. Purification and identification of individual proteins in mammalian cells have been difficult, however, due to the sheer complexity of protein mixtures obtained from cellular extracts. Recently, a tandem affinity purification (TAP) method has been developed as a tool that allows rapid purification of native protein complexes expressed at their natural level in engineered yeast cells. To adapt this method to mammalian cells, we have created a TAP tag retroviral expression vector to allow stable expression of the TAP-tagged protein at close to physiological levels. To demonstrate the utility of this vector, we have fused a TAP tag, consisting of a protein A tag, a cleavage site for the tobacco etch virus (TEV) protease, and the FLAG epitope, to the N terminus of human SMAD3 and SMAD4. We have stably expressed these proteins in mammalian cells at desirable levels by retroviral gene transfer and purified native SMAD3 protein complexes from cell lysates. The combination of two different affinity tags greatly reduced the number of nonspecific proteins in the mixture. We have identified HSP70 as a specific interacting protein of SMAD3. We demonstrated that SMAD3, but not SMAD1, binds HSP70 in vivo, validating the TAP purification approach. This method is applicable to virtually any protein and provides an efficient way to purify unknown proteins to homogeneity from the complex mixtures found in mammalian cell lysates in preparation for identification by mass spectrometry.

17 April 2008 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
KMKrista D Meyer
Krista D Meyer
ADAaron J Donner
Aaron J Donner
MKMatthew T Knuesel
Matthew T Knuesel
AYAutumn G York
Autumn G York
JEJoaquín M Espinosa
Joaquín M Espinosa
DTDylan J Taatjes
Dylan J Taatjes
The human Mediator complex is generally required for expression of protein‐coding genes. Here, we show that the GCN5L acetyltransferase stably associates with Mediator together with the TRRAP polypeptide. Yet, contrary to expectations, TRRAP/GCN5L does not associate with the transcriptionally active core Mediator but rather with Mediator that contains the cdk8 subcomplex. Consequently, this derivative ‘T/G‐Mediator’ complex does not directly activate transcription in a reconstituted human transcription system. However, within T/G‐Mediator, cdk8 phosphorylates serine‐10 on histone H3, which in turn stimulates H3K14 acetylation by GCN5L within the complex. Tandem phosphoacetylation of H3 correlates with transcriptional activation, and ChIP assays demonstrate co‐occupancy of T/G‐Mediator components at several activated genes in vivo. Moreover, cdk8 knockdown causes substantial reduction of global H3 phosphoacetylation, suggesting that T/G‐Mediator is a major regulator of this H3 mark. Cooperative H3 modification provides a mechanistic basis for GCN5L association with cdk8‐Mediator and also identifies a biochemical means by which cdk8 can indirectly activate gene expression. Indeed our results suggest that T/G‐Mediator directs early events—such as modification of chromatin templates—in transcriptional activation.

1 October 2005 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
MKMatthew Knuesel
Matthew Knuesel
HCHiu Tom Cheung
Hiu Tom Cheung
MHMicah Hamady
Micah Hamady
KBKristen K. B. Barthel
Kristen K. B. Barthel
XLXuedong Colorado- Liu
Xuedong Colorado- Liu
Post-translational modification by small ubiquitin-like modifier 1 (SUMO-1) is a highly conserved process from yeast to humans and plays important regulatory roles in many cellular processes. Sumoylation occurs at certain internal lysine residues of target proteins via an isopeptide bond linkage. Unlike ubiquitin whose carboxyl-terminal sequence is RGG, the tripeptide at the carboxyl terminus of SUMO is TGG. The presence of the arginine residue at the carboxyl terminus of ubiquitin allows tryptic digestion of ubiquitin conjugates to yield a signature peptide containing a diglycine remnant attached to the target lysine residue and rapid identification of the ubiquitination site by mass spectrometry. The absence of lysine or arginine residues in the carboxyl terminus of mammalian SUMO makes it difficult to apply this approach to mapping sumoylation sites. We performed Arg scanning mutagenesis by systematically substituting amino acid residues surrounding the diglycine motif and found that a SUMO variant terminated with RGG can be conjugated efficiently to its target protein under normal sumoylation conditions. We developed a Programmed Data Acquisition (PDA) mass spectrometric approach to map target sumoylation sites using this SUMO variant. A web-based computational program designed for efficient identification of the modified peptides is described.